Investigation of PARP-1, PARP-2, and PARG Interactomes by Affinity-purification Mass Spectrometry

Overview

Journal Proteome Sci

Publisher Biomed Central

Date 2010 Apr 15

PMID 20388209

Citations 73

Authors

Maxim Isabelle

Xavier Moreel

Jean-Philippe Gagne

Michele Rouleau

Chantal Ethier

Pierre Gagne

Michael J Hendzel

Guy G Poirier

Affiliations

Soon will be listed here.

Abstract

Background: Poly(ADP-ribose) polymerases (PARPs) catalyze the formation of poly(ADP-ribose) (pADPr), a post-translational modification involved in several important biological processes, namely surveillance of genome integrity, cell cycle progression, initiation of the DNA damage response, apoptosis, and regulation of transcription. Poly(ADP-ribose) glycohydrolase (PARG), on the other hand, catabolizes pADPr and thereby accounts for the transient nature of poly(ADP-ribosyl)ation. Our investigation of the interactomes of PARP-1, PARP-2, and PARG by affinity-purification mass spectrometry (AP-MS) aimed, on the one hand, to confirm current knowledge on these interactomes and, on the other hand, to discover new protein partners which could offer insights into PARPs and PARG functions.

Results: PARP-1, PARP-2, and PARG were immunoprecipitated from human cells, and pulled-down proteins were separated by gel electrophoresis prior to in-gel trypsin digestion. Peptides were identified by tandem mass spectrometry. Our AP-MS experiments resulted in the identifications of 179 interactions, 139 of which are novel interactions. Gene Ontology analysis of the identified protein interactors points to five biological processes in which PARP-1, PARP-2 and PARG may be involved: RNA metabolism for PARP-1, PARP-2 and PARG; DNA repair and apoptosis for PARP-1 and PARP-2; and glycolysis and cell cycle for PARP-1.

Conclusions: This study reveals several novel protein partners for PARP-1, PARP-2 and PARG. It provides a global view of the interactomes of these proteins as well as a roadmap to establish the systems biology of poly(ADP-ribose) metabolism.

Citing Articles

Novel inhibitors of PARP1 and PARP14: design, synthesis, and potentiation of cisplatin efficacy in cancer.

Kam C, Tauber A, Zunk M, McDermott C, Levonis S, Schweiker S Future Med Chem. 2024; 17(1):35-58.

PMID: 39691063 PMC: 11703142. DOI: 10.1080/17568919.2024.2437972.

PARP-1 selectively impairs -driven phenotypic and molecular features in intrahepatic cholangiocarcinoma.

Keggenhoff F, Castven D, Becker D, Stojkovic S, Castven J, Zimpel C Gut. 2024; 73(10):1712-1724.

PMID: 38857989 PMC: 11420749. DOI: 10.1136/gutjnl-2023-331237.

Specific and shared biological functions of PARP2 - is PARP2 really a lil' brother of PARP1?.

Szanto M, Yelamos J, Bai P Expert Rev Mol Med. 2024; 26:e13.

PMID: 38698556 PMC: 11140550. DOI: 10.1017/erm.2024.14.

Cooperative nucleic acid binding by Poly ADP-ribose polymerase 1.

Melikishvili M, Fried M, Fondufe-Mittendorf Y Sci Rep. 2024; 14(1):7530.

PMID: 38553566 PMC: 10980755. DOI: 10.1038/s41598-024-58076-w.

An integrative proteomics approach identifies tyrosine kinase KIT as a therapeutic target for SPINK1-positive prostate cancer.

Manzar N, Khan U, Goel A, Carskadon S, Gupta N, Palanisamy N iScience. 2024; 27(3):108794.

PMID: 38384854 PMC: 10879682. DOI: 10.1016/j.isci.2024.108794.

References

Saxena A, Saffery R, Wong L, Kalitsis P, Choo K . Centromere proteins Cenpa, Cenpb, and Bub3 interact with poly(ADP-ribose) polymerase-1 protein and are poly(ADP-ribosyl)ated. J Biol Chem. 2002; 277(30):26921-6. DOI: 10.1074/jbc.M200620200. View

Andrabi S, Dawson T, Dawson V . Mitochondrial and nuclear cross talk in cell death: parthanatos. Ann N Y Acad Sci. 2008; 1147:233-41. PMC: 4454457. DOI: 10.1196/annals.1427.014. View

Keller A, Nesvizhskii A, Kolker E, Aebersold R . Empirical statistical model to estimate the accuracy of peptide identifications made by MS/MS and database search. Anal Chem. 2002; 74(20):5383-92. DOI: 10.1021/ac025747h. View

Ravagnan L, Gurbuxani S, Susin S, Maisse C, Daugas E, Zamzami N . Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat Cell Biol. 2001; 3(9):839-43. DOI: 10.1038/ncb0901-839. View

Hirosawa M, HOSHIDA M, Ishikawa M, Toya T . MASCOT: multiple alignment system for protein sequences based on three-way dynamic programming. Comput Appl Biosci. 1993; 9(2):161-7. DOI: 10.1093/bioinformatics/9.2.161. View

Fossati S, Formentini L, Wang Z, Moroni F, Chiarugi A . Poly(ADP-ribosyl)ation regulates heat shock factor-1 activity and the heat shock response in murine fibroblasts. Biochem Cell Biol. 2006; 84(5):703-12. DOI: 10.1139/o06-083. View

Verrax J, Vanbever S, Stockis J, Taper H, Buc Calderon P . Role of glycolysis inhibition and poly(ADP-ribose) polymerase activation in necrotic-like cell death caused by ascorbate/menadione-induced oxidative stress in K562 human chronic myelogenous leukemic cells. Int J Cancer. 2006; 120(6):1192-7. DOI: 10.1002/ijc.22439. View

Rao R, Peel A, Logvinova A, Del Rio G, Hermel E, Yokota T . Coupling endoplasmic reticulum stress to the cell death program: role of the ER chaperone GRP78. FEBS Lett. 2002; 514(2-3):122-8. PMC: 3971841. DOI: 10.1016/s0014-5793(02)02289-5. View

Schreiber V, Ame J, Dolle P, Schultz I, Rinaldi B, Fraulob V . Poly(ADP-ribose) polymerase-2 (PARP-2) is required for efficient base excision DNA repair in association with PARP-1 and XRCC1. J Biol Chem. 2002; 277(25):23028-36. DOI: 10.1074/jbc.M202390200. View

10.

Trucco C, Rolli V, Oliver F, Flatter E, Masson M, Dantzer F . A dual approach in the study of poly (ADP-ribose) polymerase: in vitro random mutagenesis and generation of deficient mice. Mol Cell Biochem. 1999; 193(1-2):53-60. View

11.

Malanga M, Czubaty A, Girstun A, Staron K, Althaus F . Poly(ADP-ribose) binds to the splicing factor ASF/SF2 and regulates its phosphorylation by DNA topoisomerase I. J Biol Chem. 2008; 283(29):19991-8. DOI: 10.1074/jbc.M709495200. View

12.

Rouleau M, Patel A, Hendzel M, Kaufmann S, Poirier G . PARP inhibition: PARP1 and beyond. Nat Rev Cancer. 2010; 10(4):293-301. PMC: 2910902. DOI: 10.1038/nrc2812. View

13.

Cheng H, Dufu K, Lee C, Hsu J, Dias A, Reed R . Human mRNA export machinery recruited to the 5' end of mRNA. Cell. 2006; 127(7):1389-400. DOI: 10.1016/j.cell.2006.10.044. View

14.

Veuger S, Curtin N, Smith G, Durkacz B . Effects of novel inhibitors of poly(ADP-ribose) polymerase-1 and the DNA-dependent protein kinase on enzyme activities and DNA repair. Oncogene. 2004; 23(44):7322-9. DOI: 10.1038/sj.onc.1207984. View

15.

Gagne J, Bonicalzi M, Gagne P, Ouellet M, Hendzel M, Poirier G . Poly(ADP-ribose) glycohydrolase is a component of the FMRP-associated messenger ribonucleoparticles. Biochem J. 2005; 392(Pt 3):499-509. PMC: 1316289. DOI: 10.1042/BJ20050792. View

16.

Caldecott K . XRCC1 and DNA strand break repair. DNA Repair (Amst). 2003; 2(9):955-69. DOI: 10.1016/s1568-7864(03)00118-6. View

17.

. The Gene Ontology project in 2008. Nucleic Acids Res. 2007; 36(Database issue):D440-4. PMC: 2238979. DOI: 10.1093/nar/gkm883. View

18.

Rancourt A, Satoh M . Delocalization of nucleolar poly(ADP-ribose) polymerase-1 to the nucleoplasm and its novel link to cellular sensitivity to DNA damage. DNA Repair (Amst). 2009; 8(3):286-97. DOI: 10.1016/j.dnarep.2008.11.018. View

19.

Powers M, Clarke P, Workman P . Dual targeting of HSC70 and HSP72 inhibits HSP90 function and induces tumor-specific apoptosis. Cancer Cell. 2008; 14(3):250-62. DOI: 10.1016/j.ccr.2008.08.002. View

20.

Kirchhoff S, Gupta S, Knowlton A . Cytosolic heat shock protein 60, apoptosis, and myocardial injury. Circulation. 2002; 105(24):2899-904. DOI: 10.1161/01.cir.0000019403.35847.23. View